Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

Objectives Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We a...

Full description

Bibliographic Details
Main Authors:	Paul N Newton, Patricia Tabernero
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	BMJ Global Health
Online Access:	https://gh.bmj.com/content/8/7/e012039.full

Similar Items

Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance
by: Tabernero, P, et al.
Published: (2023)

Is neglect of self-clearance biasing TB vaccine impact estimates?
by: Richard White, et al.
Published: (2023-08-01)

Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB
by: Aline Ferreira Placeres, et al.
Published: (2023-01-01)

TB drug prices slashed for poor countries
by: Michael Hagmann

Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature
by: Afsatou Ndama Traoré, et al.
Published: (2022-06-01)

The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015
by: Mario C Raviglione
Published: (2007-05-01)

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study
by: Dirie AMH, et al.
Published: (2022-12-01)

‘TB OR NOT TB?’: The Importance of Appropriate Screening
by: Ana Pereira Lemos, et al.
Published: (2021-03-01)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
by: Malaisamy Muniyandi, et al.
Published: (2023-08-01)

tb
by: Daily, Sin Chew
Published: (2014)

Debate - TB or XDR TB, should that be the question?
by: Andrew Black
Published: (2007-04-01)

Stark Width Data for Tb II, Tb III and Tb IV Spectral Lines
by: Milan S. Dimitrijević
Published: (2021-03-01)

Quality of the life of the TB patients
by: V. B. Zafirova, et al.
Published: (2015-04-01)

New global plan to halt TB
by: Sheila Davey
Published: (2001-01-01)

TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi
by: Knut Lönnroth, et al.
Published: (2022-05-01)

World TB Day 2016: Unite to End TB
by: Editorial Article
Published: (2016-02-01)

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
by: I. V. Peretokina, et al.
Published: (2018-12-01)

Innovative approach to delivery of TB Medicines: ANYWHERE MEDICINES (AWM)
by: Yatin Dholakia
Published: (2023-01-01)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
by: Srinath Satyanarayana, et al.
Published: (2023-04-01)

Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
by: Gifty Marley, et al.
Published: (2023-01-01)

Coordinated In Vitro Release of Granulysin, Perforin and IFN-γ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment
by: Nada Pitabut, et al.
Published: (2020-08-01)

MODERN MEASURES OF ANTI-TB INFECTION CONTROL
by: 10.25005/2074-0581-2019-21-2-298-304, et al.
Published: (2019-06-01)

TB guidelines.
by: Cookson, J, et al.
Published: (2000)

RELATIONSHIP BETWEEN DETECTION OF TB AND TREATMENT OF MDR/XDR TB
by: V. Guseva, et al.
Published: (2023-08-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries.
by: Alexander Jarde, et al.
Published: (2022-01-01)

Addressing TB multimorbidity in policy and practice: An exploratory survey of TB providers in 27 high-TB burden countries
by: Alexander Jarde, et al.
Published: (2022-01-01)

TB prevalence down 30% in China after DOTS

TB prevalence down 30% in China after DOTS
Published: (2004-09-01)

EXTENSIVELY DRUG RESISTANT TUBERCULOSIS (XDR TB)
by: Sarah Rahmayani Siregar
Published: (2019-12-01)

Invest to end TB. Save lives”- World TB Day 2022
by: A. I. Ruwanpura
Published: (2022-05-01)

The TB REACH Initiative: Supporting TB Elimination Efforts in the Asia-Pacific
by: Jacob Creswell, et al.
Published: (2020-10-01)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients
by: Guo J, et al.
Published: (2023-06-01)

Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
by: Shan Zhou, et al.
Published: (2021-11-01)

Prevalence of Latent TB Infection among Health Care Workers in Three Main TB Health Facilities, Baghdad, Iraq, 2013
by: Alaa H. Al-Ameri, et al.
Published: (2014-10-01)

Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017–2019
by: Sizulu Moyo, et al.
Published: (2023-01-01)

Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017-2019.
by: Sizulu Moyo, et al.
Published: (2023-01-01)

Diagnostic interaction between bovine tuberculosis (bTB) and Johne's disease in bTB highly prevalent dairy farms of Uruguay
by: C. Picasso-Risso, et al.
Published: (2019-06-01)

Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
by: Victor Abiola Adepoju, et al.
Published: (2023-09-01)